tyramine has been researched along with Akinetic-Rigid Variant of Huntington Disease in 2 studies
Excerpt | Relevance | Reference |
---|---|---|
"In patients with Huntington's disease, there is a mutation in the gene encoding the protein huntingtin, which results in an expanded polyglutamine sequence leading to degeneration of the basal ganglia." | 1.33 | Enhanced toxicity to the catecholamine tyramine in polyglutamine transfected SH-SY5Y cells. ( Dimayuga, ER; Keller, JN; Maragos, WF; Smith, RR, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Smith, RR | 1 |
Dimayuga, ER | 1 |
Keller, JN | 1 |
Maragos, WF | 1 |
Dill, RE | 1 |
Dorris, RL | 1 |
Phillips-Thonnard, I | 1 |
2 other studies available for tyramine and Akinetic-Rigid Variant of Huntington Disease
Article | Year |
---|---|
Enhanced toxicity to the catecholamine tyramine in polyglutamine transfected SH-SY5Y cells.
Topics: Catalase; Cell Line; Deferoxamine; DNA; Dopamine; Humans; Huntington Disease; Hydrogen Peroxide; Iro | 2005 |
A pharmacologic model of Huntington's chorea.
Topics: Animals; Carbachol; Catheterization; Clozapine; Corpus Striatum; Disease Models, Animal; Dyskinesia, | 1976 |